29-Oct-2025
Chemists design candidate drug against diabetes
University at Albany, SUNYPeer-Reviewed Publication
Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound healing in people with diabetes. The breakthrough could offer a new therapeutic option for stopping the harmful effects of both type 1 and type 2 diabetes at the source.
- Journal
- Cell Chemical Biology
- Funder
- U.S. Public Health Service, NYU Histology Core, NYU Cancer Institute, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Diabetes Research Program, NYU Grossman School of Medicine